Abstract
Extracellular calcium (Ca2+e)-induced relaxation of isolated, phenylephrine (PE)-contracted mesenteric arteries is dependent on an intact perivascular sensory nerve network that expresses the Ca2+-sensing receptor (CaSR). Activation of the receptor stimulates an endocannabinoid vasodilator pathway, which is dependent on cytochrome P450 and phospholipase A2 but largely independent of the endothelium. In the present study, we determined the role of nitric oxide (NO) in perivascular nerve CaSR-mediated relaxation of PE-contracted mesenteric resistance arteries isolated from mice. Using automated wire myography, we studied the effects of NO synthase (NOS) gene knockout (NOS−/−) and pharmacologic inhibition of NOS on Ca2+e-induced relaxation of PE-contracted arteries. Endothelial NOS knockout (eNOS−/−) upregulates but neuronal NOS knockout (nNOS−/−) downregulates CaSR expression. NOS−/− reduced maximum Ca2+e-induced relaxation with no change in EC50 values, with eNOS−/− having the largest effect. The responses of vessels to calindol and Calhex 231 indicate that the CaSR mediates relaxation. l-N5-(1-iminoethyl)-ornithine reduced Ca2+e-induced relaxation of PE-contracted arteries from C57BL/6 control mice by ≈38% but had a smaller effect in vessels from eNOS−/− mice. 7-Nitroindazole had no significant effect on relaxation of arteries from NOS−/− mice, but both NG-nitro-l-arginine methylester and NG-monomethyl-l-arginine significantly reduced the relaxation maxima in all groups. Interestingly, the nNOS-selective inhibitor S-methyl-l-thiocitrulline significantly increased the EC50 value by ≈60% in tissues from C57BL/6 mice but reduced the maximum response by ≈80% in those from nNOS−/− mice. Ca2+-activated big potassium channels play a major role in the process, as demonstrated by the effect of iberiotoxin. We conclude that CaSR signaling in mesenteric arteries stimulates eNOS and NO production that regulates Ca2+e-induced relaxation.
Footnotes
- Received April 15, 2013.
- Accepted May 1, 2013.
This work was supported by the National Institutes of Health National Heart, Lung, and Blood Institute [Grants HL064761, HL059868, HL099139, and HL051952]; and National Institutes of Health National Institute on Minority Health and Health Disparities [Grant MD000175].
- Copyright © 2013 by The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|